Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy
Clinical trial NCT04237987 · UNKNOWN
Trial details
- NCT number
- NCT04237987
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-21
- Primary completion
- 2021-01-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.